Safety and Immunogenicity of Vaccines in Children with Kaposiform Hemangioendothelioma Receiving Sirolimus: A Prospective Study
Vaccination during sirolimus therapy appears to be safe and immunogenic in children with KHE. These findings support the administration of both inactivated and live-attenuated vaccines under appropriate clinical monitoring in this rare patient population.
Authors
- Zishuo Yuan
- Mei Zeng
- Yingjing Ding
- Jinɡjinɡ Li (ORCID: https://orcid.org/0000-0002-7526-5308)
- Kai Li (ORCID: https://orcid.org/0000-0001-5050-0175)
- Jing Yuan (ORCID: https://orcid.org/0000-0001-6322-0367)
- Wei Yao (ORCID: https://orcid.org/0000-0001-7907-8043)
- Zuopeng Wang (ORCID: https://orcid.org/0000-0003-3919-6701)
Institutions
- Children's Hospital of Fudan University (CN)
Publication Details
- Journal
- Vaccines
- Published
- 2025-08-26
- DOI
- https://doi.org/10.3390/vaccines13090903
- Citations
- 1
- Primary Topic
- Vascular Malformations and Hemangiomas
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- Cyrus Tang Foundation